Back to search

Finland· FI-REL-REL6919

Insulin Insulatard

A insulins and analogues for injection, intermediate-acting product, registered in Finland by GENTOFTE.

ATC A10AC

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedInsulin InsulatardATCA10ACREGISTER NO.FI-REL-REL6919PACKS LISTED0CHECKEDSeptember 27, 2026

The record

At a glance

Fimea (Finland)
Manufacturer
GENTOFTE
Country
Finland (FI)
ATC code
A10AC
ATC class
Insulins and analogues for injection, intermediate-acting
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/9ae0ac3a-5d19-49cd-924b-7c876199b38a
GET /v1/drugs/9ae0ac3a-5d19-49cd-924b-7c876199b38a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "40",
  "form": "injektioneste",
  "route": null,
  "ddd_unit": "U",
  "strength": "40 IU/ml",
  "atc_label": "Pitkävaikutteiset",
  "ma_number": "1111",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL6919",
  "authorised_at": "1965-03-03"
}

See everything about Insulin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.